Biomea Fusion, Inc.
BMEAHealthcare|Biotechnology|US
$0.57
-0.02 (-3.51%)
DCF Value
$0.98
Tangible Book / Share
$0.17
Cash / Share
$0.48
Financials
Financial Snapshot
Market Cap
$41.0M
Enterprise Value
$7.0M
Revenue (TTM)
$0.00
Net Income (TTM)
-$32.5M
Cash & Investments
$34.8M
Net Cash
$33.9M
Free Cash Flow (TTM)
-$47.1M
Operating CF (TTM)
-$47.1M
Debt/Equity
0.07
Cash Runway & Burn Rate
Cash on Hand
$34.8M
Quarterly Burn
$11.8M
Monthly Burn
$3.9M
Est. Runway
~3.0 quarters
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Investments | $239.0K | $61.7M | $173.5M | $113.0M | $176.9M | $58.3M | $55.8M | $34.8M | |
| Operating Cash Flow | -$1.3M | -$4.5M | -$35.4M | -$62.4M | -$96.6M | -$119.9M | -$70.4M | -$47.1M | |
| Free Cash Flow | -$1.3M | -$4.5M | -$38.6M | -$63.4M | -$100.0M | -$120.3M | -$70.4M | -$47.1M | |
| Capital Expenditure | $0.00 | -$51.0K | -$3.2M | -$1.0M | -$3.4M | -$362.0K | $0.00 | $0.00 | |
| Financing Cash Flow | $1.4M | $66.0M | $153.2M | $1.2M | $163.8M | $1.7M | $67.9M | $25.1M |
R&D Spending
R&D (TTM)
$40.8M
R&D Intensity
—
R&D Growth vs Prior
-34.2%
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| R&D Expense | $1.1M | $3.7M | $28.0M | $62.7M | $102.5M | $118.1M | $62.0M | $40.8M | |
| SG&A | $103.0K | $1.5M | $13.7M | $20.9M | $23.6M | $26.0M | $19.3M | $15.1M |
Income Statement
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cost of Revenue | $0.00 | $132.0K | $0.00 | $0.00 | $0.00 | $0.00 | $1.4M | $93.0K | |
| Gross Profit | $0.00 | -$132.0K | $0.00 | $0.00 | $0.00 | $0.00 | -$1.4M | -$93.0K | |
| R&D | $1.1M | $3.7M | $28.0M | $62.7M | $102.5M | $118.1M | $62.0M | $40.8M | |
| SG&A | $103.0K | $1.5M | $13.7M | $20.9M | $23.6M | $26.0M | $19.3M | $15.1M | |
| Operating Income | -$1.2M | -$5.3M | -$41.7M | -$83.6M | -$126.1M | -$144.1M | -$81.3M | -$58.1M | |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Pretax Income | -$1.2M | -$5.3M | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M | -$32.5M | |
| Net Income | -$1.2M | -$5.3M | -$41.6M | -$81.8M | -$117.3M | -$138.4M | -$61.8M | -$32.5M | |
| EPS (Diluted) | -0.11 | -0.50 | -1.74 | -2.80 | -3.44 | -3.83 | -1.18 | -0.50 | |
| EBITDA | -$1.2M | -$5.2M | -$41.3M | -$81.1M | -$115.7M | -$136.7M | -$60.4M | -$34.2M | |
| Shares Out. (M) | 10.71 | 10.71 | 23.86 | 29.27 | 34.11 | 36.11 | 52.23 | 72.36 |
Balance Sheet
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239.0K | $61.7M | $145.7M | $111.9M | $176.9M | $58.3M | $55.8M | $34.8M | |
| Short-Term Investments | $0.00 | $0.00 | $27.8M | $1.1M | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $265.0K | $62.2M | $176.6M | $117.8M | $179.2M | $68.3M | $58.0M | $36.4M | |
| Total Assets | $265.0K | $62.5M | $185.7M | $129.3M | $199.9M | $79.9M | $58.6M | $36.9M | |
| Total Current Liabilities | $286.0K | $1.6M | $4.6M | $19.1M | $22.9M | $21.7M | $11.1M | $10.5M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Liabilities | $286.0K | $57.4M | $6.9M | $20.8M | $30.7M | $28.4M | $29.0M | $24.7M | |
| Stockholders' Equity | -$21.0K | $5.2M | $178.8M | $108.5M | $169.2M | $51.6M | $29.6M | $12.1M | |
| Retained Earnings | -$2.9M | -$8.2M | -$49.7M | -$131.6M | -$248.8M | -$387.3M | -$449.0M | -$469.8M |
Cash Flow Statement
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3M | -$4.5M | -$35.4M | -$62.4M | -$96.6M | -$119.9M | -$70.4M | -$47.1M | |
| Capital Expenditure | $0.00 | -$51.0K | -$3.2M | -$1.0M | -$3.4M | -$362.0K | $0.00 | $0.00 | |
| Free Cash Flow | -$1.3M | -$4.5M | -$38.6M | -$63.4M | -$100.0M | -$120.3M | -$70.4M | -$47.1M | |
| Investing Cash Flow | $0.00 | -$51.0K | -$33.4M | $27.3M | -$2.2M | -$362.0K | $0.00 | $550.0K | |
| Financing Cash Flow | $1.4M | $66.0M | $153.2M | $1.2M | $163.8M | $1.7M | $67.9M | $25.1M | |
| Issuance of Stock | $1.4M | $65.9M | $153.2M | $0.00 | $161.8M | $1.7M | $67.9M | $25.1M | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Debt Issuance | $0.00 | $36.0K | -$36.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $0.00 | $0.00 | $6.2M | $10.3M | $14.1M | $19.1M | $9.5M | $3.2M | |
| Net Change in Cash | $161.0K | $61.5M | $84.0M | -$33.8M | $65.0M | -$118.6M | -$2.5M | -$21.0M |
Dilution Tracker
Shares outstanding grew 387.7% over 5 years — significant dilution
Shares Outstanding
72M
5-Year Share Growth
+387.7%
Stock Issuance (TTM)
$25.1M
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 10.71 | 10.71 | 23.86 | 29.27 | 34.11 | 36.11 | 52.23 | 72.36 | |
| Change vs Prior % | — | 0.0% | 122.8% | 22.7% | 16.5% | 5.9% | 44.7% | 38.5% | |
| Stock Issuance | $1.4M | $65.9M | $153.2M | $0.00 | $161.8M | $1.7M | $67.9M | $25.1M | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Stock Based Comp. | $0.00 | $0.00 | $6.2M | $10.3M | $14.1M | $19.1M | $9.5M | $3.2M |
Margins & Profitability
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| ROE % | 5704.8% | -103.0% | -23.2% | -75.4% | -69.3% | -268.4% | -209.1% | -171.2% | |
| ROA % | -452.1% | -8.5% | -22.4% | -63.3% | -58.6% | -173.2% | -105.5% | -88.2% | |
| ROIC % | 5690.5% | -8.7% | -22.9% | -75.5% | -70.3% | -238.7% | -166.2% | -212.9% |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Gross Profit | 0.0% | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Operating Income | 0.0% | -345.8% | -682.2% | -100.7% | -50.8% | -14.2% | 43.6% | |
| Net Income | 0.0% | -344.4% | -680.7% | -96.9% | -43.3% | -18.1% | 55.4% | |
| EPS (Diluted) | 0.0% | -354.5% | -248.0% | -60.9% | -22.9% | -11.3% | 69.2% | |
| Operating Cash Flow | 0.0% | -248.6% | -694.8% | -76.1% | -54.8% | -24.1% | 41.3% | |
| Free Cash Flow | 0.0% | -252.6% | -756.1% | -64.3% | -57.6% | -20.3% | 41.5% | |
| R&D Expense | 0.0% | 236.2% | 662.6% | 124.0% | 63.5% | 15.2% | -47.5% | |
| SG&A Expense | 0.0% | 1379.6% | 797.0% | 53.0% | 12.8% | 10.2% | -25.6% | |
| Total Assets | 0.0% | 23494.7% | 197.0% | -30.4% | 54.6% | -60.0% | -26.7% | |
| Book Value / Share | 0.0% | 24714.3% | 1452.3% | -50.5% | 33.8% | -71.2% | -60.4% | |
| Debt | 0.0% | 0.0% | 1000.4% | -19.8% | 350.6% | -14.8% | -81.9% | |
| Diluted Shares | 0.0% | 0.0% | 122.8% | 22.7% | 16.5% | 5.9% | 44.7% |
Valuation
P/E (TTM)At Loss
P/S0.00
P/B3.38
10Y Low / Med / High0.99 / 2.72 / 35.22
EV/EBITDAAt Loss
EV/Revenue0.00
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.98
Tangible Book / Share
$0.17
Net Current Assets / Share
$0.16
Graham Net-Net
$0.14
Cash / Share
$0.48
| Metric | Trend | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio | -154.55 | -34.00 | -4.28 | -3.01 | -4.22 | -1.01 | -1.05 | -1.14 | |
| P/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| P/B Ratio | -8668.42 | 35.22 | 0.99 | 2.27 | 2.93 | 2.72 | 2.19 | 3.38 | |
| EV/EBITDA | -151.75 | -23.23 | -0.84 | -1.69 | -2.84 | -0.66 | -0.17 | -0.21 | |
| EV/Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
-19.11
Distress
Piotroski F-Score
0
Weak
Forward Estimates (consensus)
| Metric | FY2026 | FY2027 | FY2028 |
|---|---|---|---|
| Revenue | $3.0M | $1.1M | $6.2M |
| Net Income | -$38.4M | -$42.6M | -$40.2M |
| EPS | $-0.74 | $-0.77 | $-0.79 |
| # Analysts (EPS) | 4 | 4 | 4 |